TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) just unveiled an update.
Vitrafy Life Sciences Limited has released its financial results presentation for FY25, emphasizing the confidential nature of the information and its intended audience of eligible investors. The presentation does not constitute an offer to sell securities and highlights the company’s disclaimer regarding the accuracy and completeness of the information provided.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company operating in the life sciences industry, focusing on innovative solutions and technologies. The company is listed on the Australian Securities Exchange (ASX) under the ticker VFY.
Average Trading Volume: 24,795
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$104.7M
Learn more about VFY stock on TipRanks’ Stock Analysis page.

